BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with complement-mediated and other rare diseases. We leverage our expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. We are a commercial-stage biotech company with US headquarters in Durham, North Carolina. Our European headquarters is in Dublin, Ireland, and our Discovery Center of Excellence is rooted in Birmingham, Alabama, with many other regional offices around the world. As world leaders in structure-guided drug design, we draw on the strengths and expertise of all our colleagues—from those of us in the field or behind the scenes in our labs, to others based in home offices and around the globe. To view our LinkedIn community guidelines, please visit bit.ly/BCRXGuidelines.
View Top Employees from BioCryst Pharmaceuticals, Inc.| Website | https://www.biocryst.com |
| Ticker | BCRX |
| Revenue | $20 million |
| Funding | $196 million |
| Employees | 559 (536 on RocketReach) |
| Founded | 1986 |
| Address | 4505 Emperor Blvd. Suite 200, Durham, North Carolina 27703, US |
| Phone | (919) 859-1302 |
| Fax | (919) 859-1314 |
| Technologies |
JavaScript,
HTML,
Twitter
+94 more
(view full list)
|
| Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Healthcare, Science and Engineering, Clinical Trials, Health Care, Therapeutics |
| Web Rank | 3 Million |
| Keywords | Rare Disease |
| Competitors | Affectis Pharmaceuticals, Concert Pharmaceuticals, Inc., Lycera, Mimetogen Pharmaceuticals Inc., Rigel Pharmaceuticals Inc. |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 541710 Companies |
Looking for a particular BioCryst Pharmaceuticals, Inc. employee's phone or email?
BioCryst Pharmaceuticals, Inc. Questions
The BioCryst Pharmaceuticals, Inc. annual revenue was $20 million in 2024.
John Bluth is the Chief Communications Officer of BioCryst Pharmaceuticals, Inc..
536 people are employed at BioCryst Pharmaceuticals, Inc..
BioCryst Pharmaceuticals, Inc. is based in Durham, North Carolina.
The NAICS codes for BioCryst Pharmaceuticals, Inc. are [541713, 5417, 54171, 54, 541, 541710].
The SIC codes for BioCryst Pharmaceuticals, Inc. are [283, 28].
Top BioCryst Pharmaceuticals, Inc. Employees
-
14
-
View
Anthony Doyle
Chief Financial Officer (CFO) at BioCryst Pharmaceuticals, Inc.
Chapel Hill, NC, US55+ -
ViewJohn Bluth
Chief Communications Officer at BioCryst Pharmaceuticals, Inc.
Raleigh, North Carolina, United States45+ -
View
Desiree Clemons
VP, Late Phase Clinical Operations at BioCryst Pharmaceuticals, Inc.
Raleigh, North Carolina, United States25 -
View
William Sheridan
Chief Development Officer at BioCryst Pharmaceuticals, Inc.
Santa Barbara, CA, US31 -
View
Alane Barnes
VP, General Counsel and Corporate Secretary at BioCryst Pharmaceuticals, Inc.
Chapel Hill, NC, US15 -
View
Warren English
Vice President Information Technology Services at BioCryst Pharmaceuticals, Inc.
Chapel Hill, NC, US25+
Related Companies
